Login / Signup
Dual Pathway Inhibition of Coagulation and Inflammation With Rivaroxaban: A New Therapy Paradigm Against Atherosclerosis.
Alberto Testa
Alberto Morello
Nicola Corcione
Giuseppe Biondi Zoccai
Published in:
Journal of cardiovascular pharmacology (2023)
Keyphrases
</>
oxidative stress
venous thromboembolism
atrial fibrillation
cardiovascular disease
pulmonary embolism
stem cells
type diabetes